RAFAEL HOLDINGS, INC. Sale of Stock, Consideration Received on Transaction
RAFAEL HOLDINGS, INC. (RFL) had Sale of Stock, Consideration Received on Transaction of $5.00 million as of 2020-12-31, per its 10-Q filed 2023-12-14.
Discontinued › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2023-12-14
- RAFAEL HOLDINGS, INC. sale of stock, consideration received on transaction for fiscal 2017 was $1.00M.
| Period end | Sale of Stock, Consideration Received on Transaction | Sale of Stock, Consideration Received on Transaction 12 month |
|---|---|---|
| 2020-12-31 | $5.00M 10-Q · filed 2023-12-14 | |
| 2017-07-31 | $1.00M 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |